1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Genomic Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Breast Cancer Genomic Testing
1.2.3 Lung Cancer Genomic Testing
1.2.4 Blood Cancer Genomic Testing
1.2.5 Liver Cancer Genomic Testing
1.2.6 Stomach Cancer Genomic Testing
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cancer Genomic Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Laboratories
1.3.5 Academic and Research Institutes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Genomic Testing Market Perspective (2017-2028)
2.2 Cancer Genomic Testing Growth Trends by Region
2.2.1 Cancer Genomic Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cancer Genomic Testing Historic Market Size by Region (2017-2022)
2.2.3 Cancer Genomic Testing Forecasted Market Size by Region (2023-2028)
2.3 Cancer Genomic Testing Market Dynamics
2.3.1 Cancer Genomic Testing Industry Trends
2.3.2 Cancer Genomic Testing Market Drivers
2.3.3 Cancer Genomic Testing Market Challenges
2.3.4 Cancer Genomic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Genomic Testing Players by Revenue
3.1.1 Global Top Cancer Genomic Testing Players by Revenue (2017-2022)
3.1.2 Global Cancer Genomic Testing Revenue Market Share by Players (2017-2022)
3.2 Global Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Genomic Testing Revenue
3.4 Global Cancer Genomic Testing Market Concentration Ratio
3.4.1 Global Cancer Genomic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Genomic Testing Revenue in 2021
3.5 Cancer Genomic Testing Key Players Head office and Area Served
3.6 Key Players Cancer Genomic Testing Product Solution and Service
3.7 Date of Enter into Cancer Genomic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Genomic Testing Breakdown Data by Type
4.1 Global Cancer Genomic Testing Historic Market Size by Type (2017-2022)
4.2 Global Cancer Genomic Testing Forecasted Market Size by Type (2023-2028)
5 Cancer Genomic Testing Breakdown Data by Application
5.1 Global Cancer Genomic Testing Historic Market Size by Application (2017-2022)
5.2 Global Cancer Genomic Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cancer Genomic Testing Market Size (2017-2028)
6.2 North America Cancer Genomic Testing Market Size by Type
6.2.1 North America Cancer Genomic Testing Market Size by Type (2017-2022)
6.2.2 North America Cancer Genomic Testing Market Size by Type (2023-2028)
6.2.3 North America Cancer Genomic Testing Market Share by Type (2017-2028)
6.3 North America Cancer Genomic Testing Market Size by Application
6.3.1 North America Cancer Genomic Testing Market Size by Application (2017-2022)
6.3.2 North America Cancer Genomic Testing Market Size by Application (2023-2028)
6.3.3 North America Cancer Genomic Testing Market Share by Application (2017-2028)
6.4 North America Cancer Genomic Testing Market Size by Country
6.4.1 North America Cancer Genomic Testing Market Size by Country (2017-2022)
6.4.2 North America Cancer Genomic Testing Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Cancer Genomic Testing Market Size (2017-2028)
7.2 Europe Cancer Genomic Testing Market Size by Type
7.2.1 Europe Cancer Genomic Testing Market Size by Type (2017-2022)
7.2.2 Europe Cancer Genomic Testing Market Size by Type (2023-2028)
7.2.3 Europe Cancer Genomic Testing Market Share by Type (2017-2028)
7.3 Europe Cancer Genomic Testing Market Size by Application
7.3.1 Europe Cancer Genomic Testing Market Size by Application (2017-2022)
7.3.2 Europe Cancer Genomic Testing Market Size by Application (2023-2028)
7.3.3 Europe Cancer Genomic Testing Market Share by Application (2017-2028)
7.4 Europe Cancer Genomic Testing Market Size by Country
7.4.1 Europe Cancer Genomic Testing Market Size by Country (2017-2022)
7.4.2 Europe Cancer Genomic Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Genomic Testing Market Size (2017-2028)
8.2 Asia-Pacific Cancer Genomic Testing Market Size by Type
8.2.1 Asia-Pacific Cancer Genomic Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cancer Genomic Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cancer Genomic Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Cancer Genomic Testing Market Size by Application
8.3.1 Asia-Pacific Cancer Genomic Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cancer Genomic Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cancer Genomic Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Cancer Genomic Testing Market Size by Region
8.4.1 Asia-Pacific Cancer Genomic Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cancer Genomic Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Genomic Testing Market Size (2017-2028)
9.2 Latin America Cancer Genomic Testing Market Size by Type
9.2.1 Latin America Cancer Genomic Testing Market Size by Type (2017-2022)
9.2.2 Latin America Cancer Genomic Testing Market Size by Type (2023-2028)
9.2.3 Latin America Cancer Genomic Testing Market Share by Type (2017-2028)
9.3 Latin America Cancer Genomic Testing Market Size by Application
9.3.1 Latin America Cancer Genomic Testing Market Size by Application (2017-2022)
9.3.2 Latin America Cancer Genomic Testing Market Size by Application (2023-2028)
9.3.3 Latin America Cancer Genomic Testing Market Share by Application (2017-2028)
9.4 Latin America Cancer Genomic Testing Market Size by Country
9.4.1 Latin America Cancer Genomic Testing Market Size by Country (2017-2022)
9.4.2 Latin America Cancer Genomic Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Genomic Testing Market Size (2017-2028)
10.2 Middle East & Africa Cancer Genomic Testing Market Size by Type
10.2.1 Middle East & Africa Cancer Genomic Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cancer Genomic Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cancer Genomic Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Cancer Genomic Testing Market Size by Application
10.3.1 Middle East & Africa Cancer Genomic Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cancer Genomic Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cancer Genomic Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Cancer Genomic Testing Market Size by Country
10.4.1 Middle East & Africa Cancer Genomic Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cancer Genomic Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Myriad Genetics
11.1.1 Myriad Genetics Company Details
11.1.2 Myriad Genetics Business Overview
11.1.3 Myriad Genetics Cancer Genomic Testing Introduction
11.1.4 Myriad Genetics Revenue in Cancer Genomic Testing Business (2017-2022)
11.1.5 Myriad Genetics Recent Developments
11.2 Centogene AG
11.2.1 Centogene AG Company Details
11.2.2 Centogene AG Business Overview
11.2.3 Centogene AG Cancer Genomic Testing Introduction
11.2.4 Centogene AG Revenue in Cancer Genomic Testing Business (2017-2022)
11.2.5 Centogene AG Recent Developments
11.3 Color Genomics
11.3.1 Color Genomics Company Details
11.3.2 Color Genomics Business Overview
11.3.3 Color Genomics Cancer Genomic Testing Introduction
11.3.4 Color Genomics Revenue in Cancer Genomic Testing Business (2017-2022)
11.3.5 Color Genomics Recent Developments
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Details
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Cancer Genomic Testing Introduction
11.4.4 Quest Diagnostics Revenue in Cancer Genomic Testing Business (2017-2022)
11.4.5 Quest Diagnostics Recent Developments
11.5 23andMe Inc.
11.5.1 23andMe Inc. Company Details
11.5.2 23andMe Inc. Business Overview
11.5.3 23andMe Inc. Cancer Genomic Testing Introduction
11.5.4 23andMe Inc. Revenue in Cancer Genomic Testing Business (2017-2022)
11.5.5 23andMe Inc. Recent Developments
11.6 Gene By Gene Ltd.
11.6.1 Gene By Gene Ltd. Company Details
11.6.2 Gene By Gene Ltd. Business Overview
11.6.3 Gene By Gene Ltd. Cancer Genomic Testing Introduction
11.6.4 Gene By Gene Ltd. Revenue in Cancer Genomic Testing Business (2017-2022)
11.6.5 Gene By Gene Ltd. Recent Developments
11.7 LabCorp
11.7.1 LabCorp Company Details
11.7.2 LabCorp Business Overview
11.7.3 LabCorp Cancer Genomic Testing Introduction
11.7.4 LabCorp Revenue in Cancer Genomic Testing Business (2017-2022)
11.7.5 LabCorp Recent Developments
11.8 Positive Bioscience
11.8.1 Positive Bioscience Company Details
11.8.2 Positive Bioscience Business Overview
11.8.3 Positive Bioscience Cancer Genomic Testing Introduction
11.8.4 Positive Bioscience Revenue in Cancer Genomic Testing Business (2017-2022)
11.8.5 Positive Bioscience Recent Developments
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Details
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Cancer Genomic Testing Introduction
11.9.4 Bio-Rad Laboratories Revenue in Cancer Genomic Testing Business (2017-2022)
11.9.5 Bio-Rad Laboratories Recent Developments
11.10 Illumina, Inc.
11.10.1 Illumina, Inc. Company Details
11.10.2 Illumina, Inc. Business Overview
11.10.3 Illumina, Inc. Cancer Genomic Testing Introduction
11.10.4 Illumina, Inc. Revenue in Cancer Genomic Testing Business (2017-2022)
11.10.5 Illumina, Inc. Recent Developments
11.11 Agilent Technologies
11.11.1 Agilent Technologies Company Details
11.11.2 Agilent Technologies Business Overview
11.11.3 Agilent Technologies Cancer Genomic Testing Introduction
11.11.4 Agilent Technologies Revenue in Cancer Genomic Testing Business (2017-2022)
11.11.5 Agilent Technologies Recent Developments
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Details
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Cancer Genomic Testing Introduction
11.12.4 Thermo Fisher Scientific Revenue in Cancer Genomic Testing Business (2017-2022)
11.12.5 Thermo Fisher Scientific Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
